We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current PBSV market cap is 13.55M. The company's latest EPS is USD -0.0339 and P/E is -17.40.
| Year End October 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 21.56M | 20.12M | 19.4M | 16.98M | 9.51M |
| Operating Income | 2.23M | -3.85M | 1.18M | 1.12M | -1.29M |
| Net Income | 2.05M | -2.09M | 1.01M | 1.31M | -778k |
| Year End October 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 29.92M | 23.92M | 20.65M | 19.9M | 16.29M |
| Total Liabilities | 7.2M | 5.01M | 4.09M | 3.78M | 2.58M |
| Total Equity | 22.72M | 18.91M | 16.56M | 16.13M | 13.72M |
| Year End October 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 1.53M | 805k | 593k | 1.89M | -567k |
| Investing | -29k | 1.3M | -19k | -4.22M | -1.36M |
| Financing | 194k | -1.75M | -3.53M | -1.76M | -1.73M |
| Market Cap | 13.55M |
| Price to Earnings Ratio | -17.40 |
| Price to Sales Ratio | 1.42 |
| Price to Cash Ratio | 2 |
| Price to Book Ratio | 0.99 |
| Dividend Yield | - |
| Shares Outstanding | 22.96M |
| Average Volume (1 week) | 4.93k |
| Average Volume (1 Month) | 19.95k |
| 52 Week Change | -35.87% |
| 52 Week High | 0.96 |
| 52 Week Low | 0.3127 |
| Spread (Intraday) | 0.05 (8.46%) |
| Company Name | Pharma Bio Serv Inc (QB) |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.pharmabioserv.com |
| Industry | management consulting svcs (8742) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
